VectorXcellerator Programme: Fully funded feasibility studies to support early-stage cell and gene therapy programmes

Webinar: Optimising viral vector manufacturing with CDMO expertise and innovation

News: OXB honoured at 2025 CDMO Leadership Awards Europe in ‘Cell & Gene Therapy’ category

Efficient Generation of Transgenic Pigs Using Equine Infectious Anaemia Virus (EIAV) Derived Vectorrs, implying a scalable method for large-animal transgenesis.

September 17, 2024